Welcome to our dedicated page for Reliq Helth Tech news (Ticker: RQHTF), a resource for investors and traders seeking the latest updates and insights on Reliq Helth Tech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Reliq Helth Tech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Reliq Helth Tech's position in the market.
Reliq Health Technologies Inc. (OTC: RQHTF) condemned a recent report from a short seller as defamatory and misleading, aimed at manipulating its stock price. The company noted over 5 million shares are currently shorted, a significant increase preceding the report. Despite the tumultuous healthcare landscape due to COVID-19, Reliq reported a remarkable 494% revenue growth over the past four quarters and expects to onboard over 200,000 patients by mid-2023, driven by expanding Medicare and Medicaid reimbursements. The company plans to submit evidence of false claims to the DOJ amid an ongoing investigation into short selling practices.
Reliq Health Technologies Inc. (OTC:RQHTF) announced new contracts with physician practices, a home health agency, and adult medical day care facilities in Texas, Nevada, and Maryland. These contracts are expected to onboard over 2,000 new patients, generating an average revenue of $50 per patient per month. Additionally, Reliq reported successful collection of aged accounts receivable from pandemic payment terms, with ongoing timely collections anticipated. The iUGO Care platform aims to enhance patient care through remote monitoring and telemedicine, supporting the growing needs in healthcare.
Reliq Health Technologies (OTC:RQHTF) announced its participation in the Lytham Partners Spring 2022 Investor Conference from April 4-7, 2022. CEO Dr. Lisa Crossley highlighted expectations for significant growth in 2022, supported by increased reimbursements from CMS for virtual care services through its iUGO Care platform. The company targets a patient population of over 60 million in the U.S., with recent quarterly gross margins reaching 74%. A webcast presentation will occur at 11:00 AM EDT on April 4, with a panel discussion on innovating patient care on April 5.
Reliq Health Technologies Inc. (OTC:RQHTF) has entered an agreement with a US Contract Research Organization to utilize its iUGO Care software for oncology clinical trials. The oncology market is valued at over $10 billion and is expected to grow significantly. Reliq anticipates onboarding over 3,000 patients, generating approximately $40 per patient per month in recurring revenue. This move marks Reliq's expansion into the clinical trials space, leveraging its innovative healthcare solutions to enhance patient outcomes and monitoring.
Reliq Health Technologies Inc. (OTCPink:RQHTF) has announced five new contracts with three primary care practices and two home health agencies in the U.S., enhancing its telemedicine services. The company is expanding its mental health care capabilities to include Collaborative Care Management (CoCM), which can generate additional revenue for clinicians. The contracts will bring over 2,000 new patients to Reliq's iUGO Care platform, with a potential revenue of over CDN$180,000 monthly when fully onboarded. The contracts include a one-time payment of $400,000 for medical monitoring device hardware.
Reliq Health Technologies Inc. (OTCPink:RQHTF) has announced new contracts in Nevada, partnering with a primary care organization operating six clinics and a Maxillofacial Surgery practice. This expansion is expected to onboard over 3,000 eligible patients to its iUGO Care platform, generating revenue of approximately $50 per patient per month. The company anticipates $450 in revenue per surgery for short-term monitoring and a total monthly revenue of over CDN$190,000 once fully onboarded. Reliq's innovative Virtual Care solutions aim to enhance healthcare delivery.
Reliq Health Technologies Inc. (OTC:RQHTF) has secured new contracts in Nevada, expanding its client base with a primary care organization featuring six clinics and a Maxillofacial Surgery practice. This partnership introduces over 3,000 eligible patients to its iUGO Care platform, potentially generating $50 per patient monthly. The oral surgery practice is expected to generate upwards of $450 per patient per surgery for monitoring, transitioning care back to primary physicians for ongoing revenue. This growth aligns with Reliq's strategy to enhance virtual healthcare solutions, reducing hospital readmissions.
Reliq Health Technologies (OTCPink:RQHTF) announces the signing of five new contracts with physician practices across Nevada, California, and Texas, expecting to onboard over 2,500 new patients by April. This expansion will enhance access to telemedicine services for chronic condition management. In its recent financial report, the company noted a revenue increase of over 344%, reaching approximately $3.75 million for the last two quarters of 2021. The gross margin improved to 74%, with a revenue run rate of $2 million/month as of December 2021.
Reliq Health Technologies Inc. (OTC:RQHTF) announced the signing of 5 new contracts with physician practices in Nevada, California, and Texas. The expansion includes three practices in Nevada, addressing a significant healthcare access issue for over 1 million residents with chronic conditions. The new clients are anticipated to onboard more than 2,500 patients, generating approximately $50 per patient monthly starting April 2022. Reliq's iUGO Care platform enhances virtual healthcare delivery, aiming to improve health outcomes and reduce care delivery costs.
Reliq Health Technologies Inc. (OTCQB:RQHTF) reported significant growth in its Q2 FY2022 financial results, with revenues increasing over 344% to $3.75 million compared to $843,449 in the previous half-year. Gross margin improved to 74%. The company achieved a revenue run rate of $2 million/month. Reliq has signed agreements expecting to add over 10,000 patients through new billing codes and partnerships. Working capital rose to $5.92 million while reducing current liabilities. Despite COVID challenges, the company anticipates generating $40 million CAD in revenue for Calendar Year 2022.